Combined medical, surgical and endovascular treatment of a giant cell arteritis case manifesting as upper limbs acute ischemia  by de Franciscis, Stefano et al.
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a b s t r a c t
We report a case of giant cell arteritis manifesting as upper limbs ischemia due to a complete occlu-
sion of the left subclavian artery and a high grade stenosis of the right subclavian artery. We decided
to use a combined medical, surgical and endovascular treatment followed by long term treatment withccepted 7 February 2011
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methotrexate. After 4 years the patient had no signs or symptoms of relapse. In our personal experi-
ence long term treatment with Methotrexate demonstrated a certain efﬁcacy in avoiding relapse of the
inﬂammatory phase and in maintaining stability of results in this kind of disease.
© 2011 Surgical Associates Ltd. Elsevier Ltd. Open access under CC BY-NC-ND license.. Introduction
Giant cell arteritis (GCA) is a chronic vasculitis of large and
edium size arteries affecting almost exclusively older patients
>50years). It was ﬁrst described clinically in 1890 [1], and histo-
ogically in 1932 [2].
The temporal arteries are the most commonly affected, with
ymptoms like: headache, painful thickening of the temporal
rtery, visual loss and jaw claudication.
Of the extracranial manifestations, the most frequent is steno-
is or occlusion of the subclavian and axillary artery, with loss of
eripheral pulses of the arm and upper limb claudication [3].
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Open access under CC BY-NC-ND licWe present a patient with rest pain of the upper limbs and
partial necrosis of the ﬁngers due to extra cranial GCA.
2. Case report
A 75-year-old women presented to our department with rest
pain of the upper limbs, preceded by two weeks of ingravescent
claudication, and partial necrosis of the index ﬁnger of the left hand
(Fig. 1). A complete absence of the upper limb pulses was found at
the physical examination.
Abnormalities in the following blood tests were found: elevated
erythrocyte sedimentation rate (ESR) (>30mm/h) and C-reactive
protein concentrations (CRP) (>5mg/L)which, though not diagnos-
tic, are frequently associated with primary vasculitis.
The duplex ultrasound imaging showed a complete occlusion
of the left subclavian artery and a high grade stenosis (80%) of the
right subclavian artery.
An angiographic study of the aorta and upper and lower limbs
arteries was executed which demonstrated no disease in aorta and
lower limbsand thepresenceof total occlusionof the left subclavian
artery (Fig. 2) and a sub occlusive stenosis for 8 cm of the right
subclavian artery (Fig. 3).It was decided to use a combined surgical and endovascular
treatment.
As an emergency we performed a left subclavianbrachial by-
passusingavenousgraft (the internal safenousvein) (Fig. 4) and the
second step, after 3days, was a percutaneous transluminal angio-
ense.
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Fig. 1. Partial necrosis of the II ﬁnger of the left hand.
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pFig. 2. Total occlusion of the left subclavian artery.lasty of the right subclavian artery with a right femoral approach
Fig. 5). Angiographic examination showing good results for both
surgical and endovascular) procedures was performed before hos-
ital discharge.
Fig. 3. Sub occlusive stenosis of the right subclavian artery.Fig. 4. Left subclavian-brachial by-pass using a venous graft. Brachial anastomosis.
Surgical specimens of subclavian and brachial arteries showed
histopathologic features of GCA (lymphoplasmacytic panarteritis
with a variable number of giant cells).
After surgical and endovascular procedures medical treatment
was instituted.
Medical treatment consisted of prednisone 50mg/day (25mg
twice/day) for 1 month, and then prednisone was decreased to
20mg/day (10mg twice/day) for 1 month and to 10mg/day (5mg
twice/day) for 2months.
We used cyclophosphamide for 3months (2mg/kg/day) and
then methotrexate (7.5mg/day once a week) in long-term ther-
apy for 1 year (the same treatment in use at our department for
patients with Takayasu’s arteritis [4]).
During treatment (every month for 7months and every
2months subsequently), the followingblood testswereperformed:
ESR and CRP as indices of inﬂammatory activity, blood cell count,
and hepatic procollagen type III amino-terminal propeptide PIIINP
for monitoring inﬂammation state and side effects of steroid and
cytotoxic drugs.
After two months of steroid therapy ESR and CRP decreased
normal range and remained low during cyclophosphamide and
methotrexate treatment.
The patient was reviewed every 6 month after methotrexate
long term treatment and after 4 years the patient had no signs or
symptoms of relapse (Figs. 6 and 7).
Fig. 5. Angioplasty of the right subclavian artery.
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Fig. 6. Control of the left subclavian artery after 1 month of procedure.
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[Fig. 7. Control of the left brachial artery after 1 month of procedure.
. Discussion
Giant cell arteritis (GCA) is a chronic vasculitis of large and
edium sized arteries that almost exclusively affects elderly
atients. GCA is also a heterogeneous disease with a wide range
f clinical manifestations, although none that is pathognomonic
ecause many arteries throughout the body may be affected pro-
ucing symptoms and signs that are common to other medical and
urgical conditions. The most common extracranial manifestation
f GCA is stenosis or occlusion of the subclavian and axillary artery,
ith loss of arm pulses and upper limb claudication [5–7].
Symptoms and signs of systemic inﬂammation are present in
lmost all patient [8].
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The relative merits of angioplasty and surgery in chronic arteri-
tis is a topic of continuing debate. Angioplasty and surgery are both
effective but the duration of results is controversial because of the
natural history of the disease (progressive vascular involvement
especially in areas previously unaffected). However, the problems
of surgical procedure in these cases include frequent graft reoc-
clusion, anastomotic site aneurysm and those of endovascular
procedure include early restenosis.
For medical treatment there is no consensus on the dose and
duration of steroid treatment after a histologic diagnosis of giant
cell arteritis.Most clinicians recommend treatmentwith steroids in
the active phase of disease. The active phase is determinedby either
symptomatic vasculitis or elevated markers of inﬂammation [9].
We administered the same treatment for patients with Takayasu’s
arteritis in use at our department: prednisone 50mg/day (25mg
twice/day) for 1 month, and then decreased to 20mg/day (10mg
twice/day) for 1 month and to 10mg/day (5mg twice/day) for
2months; cyclophosphamide for 3months (2mg/kg/day) and then
methotrexate (7.5mg/day once a week) in longterm therapy for 1
year.
The patient after 4 years had no signs or symptoms of relapse.
It is very difﬁcult in a case of this kind of arteritis to maintain
the stability of results both for surgical or endovascular procedures
but in our personal experience combining both procedures associ-
ated with long term treatment with methotrexate demonstrated a
certain efﬁcacy in avoiding relapse of the inﬂammatory phase and
in maintaining stability of results.
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